Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Protagonist Therapeutics, Inc. (PTGX) had Profit Margin of -41.15% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$28.32M |
|
$-11.65M |
|
-- |
|
$28.32M |
|
$47.63M |
|
$-19.31M |
|
$7.66M |
|
$-11.65M |
|
$-11.65M |
|
$-11.65M |
|
$-11.65M |
|
$-11.65M |
|
$-11.65M |
|
$-19.31M |
|
$-20.79M |
|
62.96M |
|
62.96M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$605.86M |
|
$3.53M |
|
$136.27M |
|
$742.13M |
|
$35.11M |
|
-- |
|
$17.97M |
|
$53.08M |
|
$689.05M |
|
$689.05M |
|
$689.05M |
|
61.93M |
|
| Cash Flow Statement Financials | |
$125.36M |
|
$-94.40M |
|
$11.44M |
|
$97.47M |
|
$139.88M |
|
$42.40M |
|
$13.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-68.18% |
|
-68.18% |
|
-- |
|
-41.15% |
|
|
Profit Margin |
-41.15% |
$124.82M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-1.69% |
|
-1.69% |
|
-1.57% |
|
-1.69% |
|
$11.13 |
|
$1.98 |
|
$1.99 |
|